Application |
Tumor therapy [123–126] |
Tumor therapy [134, 135] |
|
Immune therapy [117–122] |
Immune therapy [136] |
|
Thrombolysis [127] |
Neointimal hyperplasia inhibition [132, 133] |
|
Antibacterial infection [128–131] |
Hair growth recovery [87] |
|
|
Antibacterial infection [85, 137] |
|
|
Vaccine therapy [138–140] |
Preparation |
Easy [123–126] |
Dependent on cargo property [76, 78, 81, 83–91] |
Activation step |
Injected as ready to use [128, 129] |
Injected as ready to use [87, 134, 135] |
|
Drug administration following MBs injection [113–116] |
|
Activation time |
Few seconds to few minutes [104–107] |
Immediately [95–97] |
Advantages |
Easy preparation [123–126] |
Reduced systemic cytotoxicity of drug [78] |
|
|
Prolonged drug lifetime within circulation [141–143] |
Disadvantages |
Direct drug exposure in blood circulation [245] |
Poor stability, payload highly dependent on cargo property, risk of drug leakage [246] |